Followers | 17 |
Posts | 936 |
Boards Moderated | 0 |
Alias Born | 04/26/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 21, 2018 5:01:06 PM
1. IPIX files BTD application well in time. It contains roughly the same information as in their Jan and Aug 2018 corporate updates.
2. FDA rejects the application, but with guidance saying if IPIX will include certain information FDA might consider granting BTD.
3. IPIX looks around and, look, they do have it, but were just too ashamed to show it to FDA in the first try.
4. Modified BTD application gets filed sometime in August 2018.
Getting really speculative. I mean, the following is laying it really thick, but there are worse liars here around - so why not.
Term sheet was signed in August 2018. Potential suitor must have been aware of FDA's rejection and about requested additional information, took a look at IPIX additional data and concluded that IPIX probably has BTD at hand and decided to sign non-binding term sheet with IPIX.
What would the info that FDA was after be? How about this: Include patient level data for weekly cisplatin Per Protocol group. Kaplan Meier curve for it looks like the stuff below. Anybody can create it by deducting August Kaplan curves from January curves.
![](http://investorshub.advfn.com/uimage/uploads/2018/9/21/jkqywweekly_Cisplatin.png)
The really weird thing is the fact that the above Brilacidin curve still has hazard ratio edge, by Log-Rank, over Galera's GC4419, HR = 0.87 favoring Brilacidin. I guess you can now guess why I like this little scenario.
Have great weekend and do some biking :)
"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM